Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history

Annals of Oncology

Volumn 22, Issue 4, 2011, Pages 835-841

  Gioulbasanis, I ^a,b   Baracos, V E ^c   Giannousi, Z ^a   Xyrafas, A ^a   Martin, L ^c   Georgoulias, V ^a   Mavroudis, D ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b GENERAL HOSPITAL OF LARISSA   (Greece)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cachexia; Lung cancer; MNA; Nutritional assessment; Weight loss

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CREATININE; FERRITIN; HEMOGLOBIN; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRAIN METASTASIS; CACHEXIA; CANCER INCIDENCE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; LABORATORY TEST; LEUKOCYTE COUNT; LUNG CANCER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; METASTASIS POTENTIAL; NUTRITIONAL ASSESSMENT; NUTRITIONAL COUNSELING; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; THROMBOCYTE COUNT; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 79953308653     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq440     Document Type: Article

References (41)

1. Dewys WD, Begg C, Lavin PT et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69: 491-497.
2. Murry DJ, Riva L, Poplack DG. Impact of nutrition on pharmacokinetics of antineoplastic agents. Int J Cancer 1998; 11 (Suppl): 48-51.
3. Hammerlid E, Wirblad B, Sandin C et al. Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck 1998; 20: 540-548.
4. Bosaeus I. Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer 2008; 16: 447-451.
5. Muscaritoli M, Bossola M, Aversa Z et al. Prevention and treatment of cancer cachexia: new insights into and old problem. Eur J Cancer 2006; 42: 31-41.
6. MacDonald N, Easson AM, Mazurak VC et al. Understanding and managing cancer cachexia. J Am Coll Surg 2003; 197: 143-161.
7. Bruera E. Anorexia, cachexia and nutrition. Br Med J 1997; 315: 1219-1222.
8. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002; 52: 72-91.
9. Rubin H. Cancer cachexia: its correlations and causes. Proc Natl Acad Sci USA 2003; 100: 5384-5389.
10. Tisdale MJ. Pathogenesis of cancer cachexia. J Support Oncol 2003; 21: 159-168.
11. Gordon JN, Green SR, Goggin PM. Cancer cachexia. Q J Med 2005; 98: 779-788.
12. Bossola M, Pacelli F, Tortorelli A et al. Cancer cachexia: it's time for more clinical trials. Ann Surg Oncol 2006; 14: 276-285.
13. Argilés JM, López-Soriano FJ, Busquets S. Novel approaches to the treatment of cachexia. Drug Discov Today 2008; 13: 73-78.
14. Huhmann MB, Cunningham RS. Importance of nutritional screening in treatment of cancer-related weight loss. Lancet Oncol 2005; 6: 334-343.
15. American Society for Parenteral and Enteral Nutrition Board of Directors. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002; 26: SA1-SA138.
16. Spiro A, Baldwin C, Patterson A et al. The views and practice of oncologists towards nutritional support in patients receiving chemotherapy. Br J Cancer 2006; 95: 431-434.
17. Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: the Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 1996; 54: 59-65.
18. Council on Practice (COP) Quality Management Committee. Identifying patients at risk: ADA's definitions for nutrition screening and nutrition assessment. J Am Diet Assoc 1994; 94: 838-839.
19. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
20. Martin C. Calorie, protein, fluid, and micronutrient requirements. In McCallum P, Polisena C (eds), The Clinical Guide to Oncology Nutrition. Chicago, IL: The American Dietetic Association 2000; 45-60.
21. Wheatley-Price P, Ding K, Seymour L et al. Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol 2008; 26: 2350-2357.
22. National Cancer Institute. Cancer Therapy Evaluation Program, Common Toxicity Criteria. Version 2.0. Bethesda, MD: National Cancer Institute 1999.
23. Hickson M, Frost G. A comparison of three methods for estimating height in the acutely ill elderly population. J Hum Nutr Diet 2003; 6: 1-3.
24. Duguet A, Bachmann P, Lallemand Y et al. Good clinical practice in nutritional management in cancer patients: malnutrition and nutritional assessment. Bull Cancer 1999; 86: 997-1016.
25. Guigoz Y. The Mini Nutritional Assessment (MNA) review of the literature-what does it tell us? J Nutr Health Aging 2006; 10: 466-485.
26. Vellas B, Guigoz Y, Baumgartner M et al. Relationships between nutritional markers and the mini-nutritional assessment in 155 older persons. J Am Geriatr Soc 2000; 48: 1300-1309.
27. Slaviero KA, Read JA, Clarke SJ et al. Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer 2003; 46: 148-157.
28. Toliusiene J, Lesauskaite V. The nutritional status of older men with advanced prostate cancer and factors affecting it. Support Care Cancer 2004; 12: 716-719.
29. Schiffman SS, Sattely-Miller EA, Taylor EL et al. Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients. J Nutr Health Aging 2007; 11: 439-454.
30. Staal van den Brekel AJ, Dentener MA, Schols AM et al. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 1995; 13: 2600-2605.
31. Ferguson M. Patient-generated subjective global assessment. Oncology (Huntingt) 2003; 17 (Suppl 2): 13-16.
32. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002; 56: 779-785.
33. Ottery FD, Kasenic S, DeBolt S et al. Volunteer network accrues >1900 patients in 6 months to validate standardized nutritional triage. J Clin Oncol 1998; 17: A-282 (Abstr).
34. Ottery FD. Bidirectional interplay of nutrition and chemotherapy. Nestle Nutr Workshop Ser Clin Perform Programme 2000; 4: 183-206.
35. Read JA, Crockett N, Volker DH et al. Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PG-SGA). Nutr Cancer 2005; 53: 51-56.
36. Barone L, Milosavljevic M, Gazibarich B. Assessing the older person: is the MNA a more appropriate nutritional assessment tool than the SGA? J Nutr Health Aging 2003; 7: 13-17.
37. Bauer JM, Vogl T, Wicklein S et al. Comparison of the Mini Nutritional Assessment, Subjective Global Assessment, and Nutritional Risk Screening (NRS 2002) for nutritional screening and assessment in geriatric hospital patients. Z Gerontol Geriatr 2005; 38: 322-327.
38. Kyle UG, Bosaeus I, De Lorenzo AD et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004; 23: 1430-1453.
39. Nussinovitch U, Shoenfeld Y. Cachexia, malignancy and tumor necrosis factor alpha (TNF-alpha). Harefuah 2007; 146: 349-351.
40. Bossola M, Pacelli F, Tortorelli A et al. Skeletal muscle in cancer cachexia: the ideal target of drug therapy. Curr Cancer Drug Targets 2008; 8: 285-298.
41. Kamiji MM, Inui A. The role of ghrelin and ghrelin analogues in wasting disease. Curr Opin Clin Nutr Metab Care 2008; 11: 443-451.